Vaxcyte, Inc. (PCVX) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
PCVX Stock Price Trajectory (2020–2026)
As of March 1, 2026, Vaxcyte, Inc. (PCVX) trades at $61.74, representing a -15.4% return over the past year. The stock has delivered a +19.0% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $121.06 on September 19, 2024. From this peak, PCVX has corrected -49.0%, currently trading 51% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers BNTX (-2.4% 1Y), MRNA (+73.0% 1Y), and SMMT (-19.8% 1Y), PCVX has underperformed the peer group average. Compare PCVX vs BNTX →
Historical Price Data
Showing 30 of 1,436 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 59.20 | 61.80 | 59.03 | 61.74 | 61 | +2.90% |
| 2026-02-26 | 61.67 | 62.73 | 59.16 | 60.00 | 60 | -4.82% |
| 2026-02-25 | 58.00 | 64.78 | 57.38 | 63.04 | 63 | +2.75% |
| 2026-02-24 | 60.68 | 61.69 | 60.23 | 61.35 | 61 | +1.81% |
| 2026-02-23 | 58.48 | 61.04 | 58.16 | 60.26 | 60 | +2.99% |
| 2026-02-20 | 56.76 | 58.74 | 55.67 | 58.51 | 58 | +2.08% |
| 2026-02-19 | 55.93 | 57.35 | 54.40 | 57.32 | 1.12M | +2.05% |
| 2026-02-18 | 53.54 | 56.73 | 53.54 | 56.17 | 1.28M | +3.45% |
| 2026-02-17 | 55.67 | 55.67 | 53.08 | 54.30 | 63K | +0.36% |
| 2026-02-13 | 55.67 | 56.69 | 54.03 | 54.10 | 696K | -1.55% |
| 2026-02-12 | 54.66 | 55.94 | 52.63 | 54.95 | 1.05M | -0.72% |
| 2026-02-11 | 55.11 | 56.12 | 51.34 | 55.35 | 1.22M | +0.67% |
| 2026-02-10 | 55.65 | 56.44 | 54.87 | 54.98 | 837K | -1.06% |
| 2026-02-09 | 55.75 | 58.00 | 54.85 | 55.57 | 1.36M | -1.03% |
| 2026-02-06 | 55.16 | 56.45 | 54.32 | 56.15 | 1.05M | +4.16% |
| 2026-02-05 | 55.21 | 56.58 | 53.12 | 53.91 | 1.86M | -2.48% |
| 2026-02-04 | 55.75 | 56.66 | 53.28 | 55.28 | 2.29M | -0.81% |
| 2026-02-03 | 57.75 | 58.95 | 54.80 | 55.73 | 3.74M | -2.91% |
| 2026-02-02 | 53.25 | 58.26 | 53.24 | 57.40 | 3.64M | +7.15% |
| 2026-01-30 | 55.25 | 55.51 | 51.10 | 53.57 | 5.28M | +1.42% |
| 2026-01-29 | 51.52 | 52.88 | 51.20 | 52.82 | 601K | +2.82% |
| 2026-01-28 | 54.34 | 54.78 | 50.50 | 51.37 | 902K | -5.48% |
| 2026-01-27 | 53.22 | 55.11 | 52.84 | 54.35 | 676K | +1.78% |
| 2026-01-26 | 51.89 | 53.94 | 50.70 | 53.40 | 913K | +1.27% |
| 2026-01-24 | 53.75 | 56.04 | 52.68 | 52.73 | 1.97M | 0.00% |
| 2026-01-23 | 53.75 | 56.04 | 52.68 | 52.73 | 2.01M | -2.04% |
| 2026-01-22 | 50.23 | 54.22 | 49.75 | 53.83 | 2.27M | +7.19% |
| 2026-01-21 | 47.37 | 50.29 | 46.91 | 50.22 | 1.30M | +5.68% |
| 2026-01-20 | 45.52 | 47.83 | 44.85 | 47.52 | 1.28M | +2.00% |
| 2026-01-16 | 48.04 | 48.93 | 46.54 | 46.59 | 976K | -3.02% |
See PCVX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PCVX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PCVX vs AGIO
See how PCVX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has PCVX stock performed recently?
PCVX declined -15.4% over the past year, below its 5-year annualized CAGR of +19.0%. The stock trades above its 200-day moving average, reflecting the downtrend.
What is PCVX's all-time high price?
Vaxcyte, Inc. reached $121.06 on 2024-09-19. The 52-week high is $76.61. Current 1-year return of -15.4% places the stock further from historical peaks.
Where can I download PCVX historical price data?
This page provides PCVX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.